The Organisation for Economic Cooperation and Development advocates improvements in terms of the accessibility to health technologies and their safety. In a report published on Monday 16 January, a day ahead of the health ministers' meeting, the OECD says that a rebalancing is needed between the power of negotiation of paying bodies and that of producers.
The 230-page report notes that there is an ever-increasing number of expensive drugs. It highlights two trends: firstly, an...